ACT vs Psychedelic Harm Reduction & Integration (PHRI)
A side-by-side comparison of recorded mechanisms, evidence review status, related condition topics, and philosophical roots.
At a glance
Source checks, condition-specific assessments and expert review are separate steps. Each assessment applies only to its stated population and use. Topic links do not establish comparative effectiveness.
ACT
- Tradition
- Cognitive-Behavioral
- Founder
- Steven Hayes (1999)
- Review status
- 4 condition assessments available
- Official sources
Guidelines and official sources (18)
16 clinical guideline checks · 2 evidence registry checks
Read the recommendation and its scope. A source may discuss an approach without recommending it.
- Acceptance and commitment therapy for depression
Discussed in the source
The archive lists Modest under 1998 criteria, with 2015 re-evaluation pending. A registry entry does not establish a depression guideline recommendation.
Scope: ACT for depression
- Acceptance and commitment therapy for chronic pain
Discussed in the source
The archive lists Strong under 1998 criteria, with 2015 re-evaluation pending.
Scope: ACT for chronic pain
- Chronic pain (primary and secondary) in over 16s (NG193)
Recommendation for the stated population
NICE says to consider ACT or CBT for pain, delivered by appropriately trained professionals.
Scope: People aged 16 and over with chronic primary pain
- Clinical Practice Guideline for Management of PTSD and Acute Stress Disorder
Insufficient evidence for or against
VA/DoD finds insufficient evidence for or against ACT for PTSD. This assessment does not determine its status for other conditions.
Scope: Individual psychotherapy for adults with PTSD.
- Clinical Practice Guideline for the Non-Surgical Management of Hip and Knee Osteoarthritis
Discussed in the source
The appendix names ACT as an optional psychosocial or behavioral intervention, guided by availability and patient preference. This is ungraded implementation guidance, not a separately graded osteoarthritis recommendation.
Scope: Conceptual approach to chronic primary (nociplastic) pain when self-management strategies are insufficient.
- Management of Major Depressive Disorder
Recommendation for the stated population
VA/DoD suggests acceptance and commitment therapy among seven unranked psychotherapy options (weak for). Treatment strategy also depends on severity, chronicity, prior response and preference.
Scope: Adults with uncomplicated MDD choosing psychotherapy.
- Management of Major Depressive Disorder
Discussed in the source
VA/DoD strongly recommends first-line evidence-based psychotherapy, referring to the list that includes acceptance and commitment therapy. This is a class-level recommendation, with no preferred individual approach.
Scope: Pregnant or breastfeeding adults with mild-to-moderate MDD.
- Management of First-Episode Psychosis and Schizophrenia
Discussed in the source
VA/DoD suggests the acceptance/mindfulness therapy category (weak for) and explicitly includes ACT in its evidence discussion. It does not assign ACT a separate recommendation grade.
Scope: Adults with schizophrenia; psychotherapy combined with medication.
- Clinical Practice Guideline for the Management of Substance Use Disorders
Insufficient evidence for or against
The guideline reviews ACT studies and finds insufficient evidence for or against the broader mindfulness-based treatment category. This is a neutral finding for this substance-use scope.
Scope: ACT within the review of mindfulness-based treatments for substance-use disorders.
- Clinical Practice Guideline for Tobacco Use Treatment
Insufficient evidence for or against
The guideline discusses ACT and finds insufficient evidence to recommend a specific behavioral counseling approach over standard CBT. Its description of ACT is not a separate positive recommendation.
Scope: ACT compared with standard CBT for adult tobacco cessation.
- Diagnosis and Treatment of Low Back Pain
Discussed in the source
The review found no eligible ACT studies and identifies comparative ACT research as a priority. The CBT recommendation should not be presented as a separate ACT endorsement.
Scope: ACT evidence considered in the chronic low back pain review.
- Management of Headache
Discussed in the source
The recommendation is neutral for the mindfulness-based therapy category; the discussion includes ACT. It does not assign ACT a separate recommendation grade.
Scope: Mindfulness-based interventions for headache treatment or prevention.
- Tinnitus
Insufficient evidence for or against
VA/DoD names ACT among the interventions for which evidence is insufficient to recommend for or against treatment. The list is explicitly unranked.
Scope: Adults with bothersome tinnitus receiving ACT from a trained provider.
- Management of Adult Overweight and Obesity
Discussed in the source
ACT studies inform the weak recommendation for the cognitive behavioral intervention category. ACT receives no separate grade here; this is not an eating-disorder treatment recommendation.
Scope: Internalized weight bias and stigma in adult overweight/obesity care.
- Primary Care Management of Chronic Kidney Disease
Discussed in the source
The appendix names ACT among behavioral pain-management options, selected by availability and preference. This is ungraded guidance; much supporting evidence comes from people without kidney disease.
Scope: Adults with chronic kidney disease and chronic pain; self-management insufficient.
- Management of Type 2 Diabetes Mellitus
Discussed in the source
The review includes ACT within mindfulness/acceptance interventions. The graded recommendation concerns a stress-reduction programme category, without a separate ACT grade or established long-term benefit.
Scope: Adults with stress related to type 2 diabetes.
- Clinical Practice Guideline for Psychological and Other Nonpharmacological Treatment of Chronic Musculoskeletal Pain in Adults
Insufficient evidence for or against
APA finds the evidence insufficient for a recommendation in these comparisons. This is not a finding of ineffectiveness.
Scope: Adults with chronic musculoskeletal pain; ACT versus active control or usual care.
- Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders
Discussed in the source
ACT is named in the reviewed third-wave therapy category. WHO recommends that category alongside other structured therapies; it does not give ACT a separate recommendation or separate certainty rating here.
Scope: Adults with moderate-to-severe depression, within the mhGAP non-specialist-care context.
- Acceptance and commitment therapy for depression
- Focus
- Experiential + Skill
- Format
- Individual + Group
- Duration
- Short-medium
Condition-specific assessments
Each conclusion applies to the population and use described. These source-based assessments do not certify the full entry or replace expert clinical review.
Chronic Pain & Somatic Symptoms
Population and scope: People aged 16 and over with chronic primary pain, receiving ACT from an appropriately trained healthcare professional; distinguished from the broader adult chronic-musculoskeletal-pain question.
Guideline recommendation
NICE NG193 1.2.3 says to consider ACT; its rationale reports benefits but a small study base and no preference over CBT. APA’s 2024 guideline separately found evidence insufficient to recommend ACT over active control or usual care for adult chronic musculoskeletal pain. These scopes and judgments differ. The label records NICE’s qualified recommendation, not unanimous support or evidence for all pain or somatic-symptom presentations.
Source assessment dated
Psychosis & Schizophrenia Spectrum
Population and scope: Adults with psychotic symptoms receiving ACT adapted for psychosis in addition to usual psychiatric care.
Randomized studies
Bach/Hayes randomized 80 inpatients to brief ACT plus usual care or usual care and reported reduced four-month rehospitalization. A later 96-patient active-comparator trial found no primary overall mental-state advantage, with selected secondary symptom benefits. Evidence concerns adjunctive ACTp and mixed outcomes, not replacement of psychiatric treatment.
Source assessment dated
Anxiety Disorders
Population and scope: Adults with principal or co-principal generalized social anxiety disorder receiving individual ACT; this assessment does not cover every anxiety disorder.
Randomized studies
Craske et al. randomized 100 participants to ACT, CBT or waiting list; the modified intention-to-treat analysis included 87 after pretreatment exclusions. Both treatments outperformed waiting list, with no detected ACT–CBT differences on the reported outcomes. This establishes a randomized comparison in social anxiety, not formal proof of equivalence or ACT superiority. The restricted analysis and sample limit generalization.
Source assessment dated
Depression & Mood Disorders
Population and scope: Adults with major depressive disorder when choosing psychotherapy, within the VA/DoD guideline's recommendations for uncomplicated MDD.
Guideline recommendation
VA/DoD 2022 Recommendation 7 suggests ACT among several psychotherapy options, with a weak recommendation and no ranking among them. In a separate 82-person routine-practice trial, A-Tjak et al. (2018) found improvement with ACT and CBT but no significant between-group differences through six-month follow-up. This qualified recommendation does not establish ACT's superiority, and the trial's nonsignificant superiority comparison does not prove equivalence.
Source assessment dated
Psychedelic Harm Reduction & Integration (PHRI)
- Tradition
- Psychedelic
- Founder
- Various (Gorman, Nielson and colleagues) (2021)
- Review status
- Assessment not yet completed
- Focus
- Integration + Support
- Format
- Individual, group
- Duration
- Variable (brief to ongoing)
How they work
ACT
Core mechanism: Psychological flexibility through acceptance, defusion, present-moment awareness, values clarification, and committed action
Ontology: Psychological inflexibility: cognitive fusion and experiential avoidance narrow behavioral repertoire
Psychedelic Harm Reduction & Integration (PHRI)
Core mechanism: Therapy that begins after the experience is over: the therapist neither supplies nor endorses the substance, and works with whatever the person came back with, whether insight, fear, confusion, or a changed sense of their life
Ontology: Psychedelic experiences can activate deep psychological material that requires skilled therapeutic support to integrate: without integration, the experience remains unmetabolized and potentially destabilizing
Related condition topics
These editorial cross-references organize reading. A shared link does not mean both approaches are effective, recommended, or interchangeable for that condition.
3 shared · 5 ACT-only · 3 Psychedelic Harm Reduction & Integration (PHRI)-only
Linked to both entries
Linked only in the ACT entry
Linked only in the Psychedelic Harm Reduction & Integration (PHRI) entry
What each assumes — and misses
ACT
Philosophical roots: Pragmatism (James, Dewey: truth as workability); functional contextualism (Pepper); Buddhism (attachment as suffering, mindfulness); Skinner (radical behaviorism, reframed)
Blind spots: Acceptance framing can feel dismissive of legitimate suffering; metaphor-heavy approach may not land for all clients
Therapeutic voice: What if the goal isn't to get rid of the anxiety, but to take it with you toward what matters?
Psychedelic Harm Reduction & Integration (PHRI)
Philosophical roots: Zinberg (drug, set, and setting); Grof (non-ordinary states as data); Rogers (unconditional positive regard applied to substance use experiences); harm reduction philosophy (Marlatt); James (varieties of religious experience); contemplative traditions
Blind spots: Minimal controlled research; risk of implicitly endorsing illegal substance use; boundary challenges when clients seek substances through therapist; limited training standards; can attract clinicians with ideological rather than clinical orientation to psychedelics
Therapeutic voice: I'm not here to tell you whether to do it again. I do want to know what you were hoping for, and whether any of it stayed with you.
Choosing between them
ACT (Cognitive-Behavioral) and Psychedelic Harm Reduction & Integration (PHRI) (Psychedelic) come from different traditions, which means they assume different things about what a person is, what causes suffering, and what the therapeutic relationship is for. The choice between them is often less about "which works better" and more about which set of assumptions fits the client and the therapist.
For deeper coverage: see the full ACT and Psychedelic Harm Reduction & Integration (PHRI) pages, or use the interactive comparison tool to add more modalities to this comparison.